Health

Results: 913-924 of 6233

GP surgery refurbs to enable over 8 million more appointments

PR Newswire associated0

AbolerIS Pharma Announces First Cohort Dosed in Phase 1 Study of ABO21009, a Novel Anti-CD45RC Antibody, for Rheumatoid Arthritis

The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China

Cronometer Unlocks Free Women's Health Nutrition Score This May to Help Close the Nutrient Gap

PR Newswire associated0

Dawn Health and Merck Launch Next-Generation Digital Ecosystem for Growth Disorders

PR Newswire associated0

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

PR Newswire associated0

Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance

Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025

NuCana Prices $7 Million Registered Direct Offering

Business Wire logo

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease

ACCESS Newswire logo

Global Survey Reveals Urgent Gaps in Awareness, Access, and Treatment for Hepatitis D

Chris O'Connell, Chairman, Board of Directors, CorFlow

CorFlow Therapeutics Appoints Chris O'Connell as Chairman of the Board of Directors